Point72 Asset Management, L.P. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-03 5:07 pm Purchase |
2025-01-31 | 13G | Dyne Therapeutics, Inc. DYN |
Point72 Asset Management, L.P. | 5,196,597 5.100% |
5,196,597 (New Position) |
Filing |